Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Darren Wolfe

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
Molecular Biology of the Cell|June 3, 2005
Inhibition of translation initiation by volatile anesthetics involves nutrient-sensitive GCN-independent and -dependent processes in yeastLaura K Palmer, Jessica L Shoemaker, Beverly A Baptiste, et al.
Methods in Molecular Biology (Clifton, N.J.)|February 19, 2004
Delivery of herpes simplex virus-based vectors to the nervous systemJames R Goss, Atsushi Natsume, Darren Wolfe, et al.
Cold Spring Harbor Protocols|May 4, 2011
Generation of replication-competent and -defective HSV vectorsWilliam F Goins, David M Krisky, James B Wechuck, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 6, 2004
Peripherally delivered glutamic acid decarboxylase gene therapy for spinal cord injury painJun Liu, Darren Wolfe, Shuanglin Hao, et al.
Annals of Neurology|July 29, 2011
Gene therapy for pain: results of a phase I clinical trialDavid J Fink, James Wechuck, Marina Mata, et al.
Annals of Neurology|January 10, 2002
In vivo gene therapy for pyridoxine-induced neuropathy by herpes simplex virus-mediated gene transfer of neurotrophin-3Munmun Chattopadhyay, Darren Wolfe, Shaohua Huang, et al.
Biotechnology and Bioengineering|January 25, 2002
Effect of genetic background and culture conditions on the production of herpesvirus-based gene therapy vectorsAli Ozuer, James B Wechuck, William F Goins, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 6, 2004
Prolonged biologically active transgene expression driven by HSV LAP2 in brain in vivoVeljko Puskovic, Darren Wolfe, James Goss, et al.
Methods in Molecular Biology (Clifton, N.J.)|February 19, 2004
Gene transfer to glial tumors using herpes simplex virusAjay Niranjan, Darren Wolfe, Wendy Fellows, et al.
Journal of Neurotrauma|February 21, 2002
Bcl-2 and GDNF delivered by HSV-mediated gene transfer after spinal root avulsion provide a synergistic effectAtsushi Natsume, Marina Mata, Darren Wolfe, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Molecular Biology of the Cell|June 3, 2005
Inhibition of translation initiation by volatile anesthetics involves nutrient-sensitive GCN-independent and -dependent processes in yeastLaura K Palmer, Jessica L Shoemaker, Beverly A Baptiste, et al.
Methods in Molecular Biology (Clifton, N.J.)|February 19, 2004
Delivery of herpes simplex virus-based vectors to the nervous systemJames R Goss, Atsushi Natsume, Darren Wolfe, et al.
Cold Spring Harbor Protocols|May 4, 2011
Generation of replication-competent and -defective HSV vectorsWilliam F Goins, David M Krisky, James B Wechuck, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 6, 2004
Peripherally delivered glutamic acid decarboxylase gene therapy for spinal cord injury painJun Liu, Darren Wolfe, Shuanglin Hao, et al.
Annals of Neurology|July 29, 2011
Gene therapy for pain: results of a phase I clinical trialDavid J Fink, James Wechuck, Marina Mata, et al.
Annals of Neurology|January 10, 2002
In vivo gene therapy for pyridoxine-induced neuropathy by herpes simplex virus-mediated gene transfer of neurotrophin-3Munmun Chattopadhyay, Darren Wolfe, Shaohua Huang, et al.
Biotechnology and Bioengineering|January 25, 2002
Effect of genetic background and culture conditions on the production of herpesvirus-based gene therapy vectorsAli Ozuer, James B Wechuck, William F Goins, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 6, 2004
Prolonged biologically active transgene expression driven by HSV LAP2 in brain in vivoVeljko Puskovic, Darren Wolfe, James Goss, et al.
Methods in Molecular Biology (Clifton, N.J.)|February 19, 2004
Gene transfer to glial tumors using herpes simplex virusAjay Niranjan, Darren Wolfe, Wendy Fellows, et al.
Journal of Neurotrauma|February 21, 2002
Bcl-2 and GDNF delivered by HSV-mediated gene transfer after spinal root avulsion provide a synergistic effectAtsushi Natsume, Marina Mata, Darren Wolfe, et al.
Pageof 4